Masahiro Shigeta
Overview
Explore the profile of Masahiro Shigeta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
304
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sone D, Beheshti I, Tagai K, Kameyama H, Takasaki E, Kashibayashi T, et al.
Psychiatry Clin Neurosci
. 2025 Jan;
PMID: 39821434
Aim: Despite the clinical importance and significant social burden of neuropsychiatric symptoms (NPS) in dementia, the underlying neurobiological mechanism remains poorly understood. Recently, neuroimaging-derived brain-age estimation by machine-learning analysis has...
2.
Asano T, Yasuda A, Kinoshita S, Tanaka T, Sahara T, Tanaka T, et al.
Nihon Ronen Igakkai Zasshi
. 2024 Sep;
61(3):337-344.
PMID: 39261104
Aim: An easy-to-use tool that can detect cognitive decline in mild cognitive impairment (MCI) is required. In this study, we aimed to construct a machine learning model that discriminates between...
3.
Hayashi D, Yamazaki R, Matsuda Y, Igarashi S, Taruishi N, Kodaka F, et al.
Neuropsychobiology
. 2024 Jun;
83(3-4):152-159.
PMID: 38889691
Introduction: The clinical efficacy of repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant depression (TRD) in Japan has not been adequately investigated. Furthermore, the relationship between stimulation-site pain and the antidepressant...
4.
Matsuda Y, Terada R, Yamada K, Yamazaki R, Nunomura A, Shigeta M, et al.
PCN Rep
. 2024 Jun;
1(2):e11.
PMID: 38868645
No abstract available.
5.
Asano T, Yasuda A, Kinoshita S, Nomoto J, Kato T, Suzuki C, et al.
Cureus
. 2024 May;
16(4):e58781.
PMID: 38784298
Background Screening tests reveal the early signs of cognitive decline, enabling better self-care and preparation for the future. We developed and evaluated the accuracy of a rapid (20 s) and...
6.
Hotchi A, Yamadera W, Iwashita M, Utsumi T, Amagai M, Nakamura S, et al.
Biopsychosoc Med
. 2024 May;
18(1):13.
PMID: 38760779
Background: Cognitive behavioral therapy for insomnia (CBT-I) is among the recommended non-pharmacological treatments for patients with insomnia. While there are multiple reports on the effects of CBT-I treatment, few studies...
7.
Kameyama H, Sugimoto K, Kodaka F, Okuno K, Masaki T, Nukariya K, et al.
Neuropsychopharmacol Rep
. 2024 Mar;
44(2):410-416.
PMID: 38494338
Aim: Numerous recent reports have highlighted the association between mental disorders and electrocardiographic findings. The early repolarization pattern (ERP) on electrocardiogram has been linked with a history of suicide attempts...
8.
Amagai M, Ozone M, Utsumi T, Hotchi A, Iwashita M, Yamadera W, et al.
Sleep Biol Rhythms
. 2024 Mar;
21(3):299-308.
PMID: 38469082
Supplementary Information: The online version contains supplementary material available at 10.1007/s41105-023-00446-4.
9.
Iwashita M, Yamadera W, Hotchi A, Utsumi T, Amagai M, Ishii J, et al.
Sleep Biol Rhythms
. 2024 Mar;
20(4):489-497.
PMID: 38468614
Cognitive behavioral therapy for insomnia (CBT-I) is effective for not only primary insomnia (PI) but also comorbid insomnia (CI; insomnia associated with psychiatric/physical diseases or other types of sleep disorders)....
10.
Kobayashi N, Shimada K, Ishii A, Osaka R, Nishiyama T, Shigeta M, et al.
iScience
. 2024 Feb;
27(3):109203.
PMID: 38414857
The heritability of major depressive disorder (MDD) is reportedly 30-50%. However, the genetic basis of its heritability remains unknown. Within SITH-1, a risk factor for MDD in human herpesvirus 6B...